Work

Characterization of Nevirapine Resistance Mutations in Women With Subtype A Vs. D HIV-1 6???8 Weeks After Single-Dose Nevirapine (HIVNET 012)

Year: 2004

Type: article

Source: JAIDS Journal of Acquired Immune Deficiency Syndromes

DOI: 10.1097/00126334-200402010-00004

Authors: Susan H. Eshleman, Laura A. Guay, Anthony Mwatha, Elizabeth R. Brown, Shawn P. Cunningham, Philippa Musoke, Francis Mmiro, J. Brooks Jackson

Institutions: Johns Hopkins University, Johns Hopkins Medicine, Johns Hopkins Hospital, Fred Hutch Cancer Center, University of Washington, Makerere University

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute of Allergy and Infectious Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: STATISTICAL &CLINICAL COORDINATING CENTER (SC), G1174034350, G445713723, HPTN - CENTRAL LABORATORY, INTNL.VACC.EFFICACY TRIALS MASTER CONTRACT (IMC), Drug Resistance in Non-Subtype B HIV-1, MU-JHU HPTU TRIAL SITE - UGANDA, G807554087, G8639351105

OpenAlex ID: W1987037885

FWCI: 10.16

Cites: 11

Cited by: 105

Related to: 10